The Effect of Self-Acupressure Application on Functional Composite and Quality of Life in Multiple Sclerosis Patients
July 16, 2021 updated by: Zülfünaz ÖZER, Istanbul Sabahattin Zaim University
It is important to consider the functional composite and quality of life of patients with multiple sclerosis (MS) and to plan interventions for these problems.
Study Overview
Detailed Description
The application of Self-Acupressure helps in improving the functional composite and quality of life in Multiple Sclerosis patients.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
State
-
Istanbul, State, Turkey, 34303
- Istanbul Sabahattin Zain Universitiy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- To be able to communicate adequately
- Not having psychiatric problems
- Volunteering to participate in research
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Self-Acupressure
Each application to the acupressure points (H17, L14, ST36, SP6) will be done in 2 minutes and right and left)
|
Acupressure is a therapy method performed with an instrument or hand, fingertip, palm, elbow, knee, thumb relaxation and wrist bands on various points representing the waist organs in order to ensure the continuation and balance of the energy in our body.
|
|
NO_INTERVENTION: No Intervention
Control group Routine maintenance will be applied
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multiple Sclerosis Functional Composite (MSFC)
Time Frame: 1. week
|
The conventional MSFC battery (MSFC3), comprising the 25 foot timed walk test (TWT), 9-hole peg test (9HPT) and paced auditory serial addition test (PASAT) was performed according to standardised procedures, calculated according to the standard manual, and normalised to this cohort.
|
1. week
|
|
Multiple Sclerosis Functional Composite (MSFC)
Time Frame: 4. week
|
The conventional MSFC battery (MSFC3), comprising the 25 foot timed walk test (TWT), 9-hole peg test (9HPT) and paced auditory serial addition test (PASAT) was performed according to standardised procedures, calculated according to the standard manual, and normalised to this cohort.
|
4. week
|
|
Multiple Sclerosis Quality of Life Scale-54
Time Frame: 1.week
|
This scale was developed by Vickrey et al17 to evaluate the quality of life of patients with The scale was created by adding 18 MS-related items to SF-36 (short form).
Physical and mental health composite scores are calculated, and higher scores indicate better quality of life.
The Turkish version was developed by Tulek et al.
|
1.week
|
|
Multiple Sclerosis Quality of Life Scale-54
Time Frame: 4.week
|
This scale was developed by Vickrey et al17 to evaluate the quality of life of patients with The scale was created by adding 18 MS-related items to SF-36 (short form).
Physical and mental health composite scores are calculated, and higher scores indicate better quality of life.
The Turkish version was developed by Tulek et al.
|
4.week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 1, 2021
Primary Completion (ACTUAL)
June 1, 2021
Study Completion (ACTUAL)
July 15, 2021
Study Registration Dates
First Submitted
June 15, 2021
First Submitted That Met QC Criteria
June 16, 2021
First Posted (ACTUAL)
June 23, 2021
Study Record Updates
Last Update Posted (ACTUAL)
July 22, 2021
Last Update Submitted That Met QC Criteria
July 16, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 26915
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.